Chikungunya in Indonesia, and the vaccine aimed at long stays

NaTHNaC's assessment is a single line: “There is a risk of chikungunya in this country.” No region is singled out.

The disease it describes as “a viral infection spread by mosquitoes which bite mainly during daytime hours. It causes a flu-like illness and can cause severe joint and muscles pains which usually improve in 1–2 weeks but may persist for months or years. It is rarely fatal.”

That sentence holds the whole case. For most people chikungunya is a bad fortnight. For some, the joint pain does not leave — and “months or years” is a very different proposition for someone who has moved their life to Indonesia than for a tourist going home next week.

The prevention line is the same as for dengue and Zika, which share the daytime-biting pattern: “Travellers should avoid mosquito bites, particularly during daytime hours.”

Source: NaTHNaC — Indonesia country information, read 6 October 2026. Also listed by the US CDC's Indonesia traveller page, read 6 October 2026.

NaTHNaC states that chikungunya vaccination “may be considered” for people aged 12 and over who are:

• travelling to regions with a current chikungunya outbreak
• long-term or frequent travellers to regions with an increased risk of chikungunya
• exposed to the virus through their work, such as laboratory staff

The second line is the one that applies to a mover. A KITAS holder, a retiree, a remote worker staying a year — all are long-term travellers on NaTHNaC's own wording.

Two honest caveats. First, the language is “may be considered”, not “recommended” — this is a decision to make with a clinician, not a default. Second, the guidance is still settling: NaTHNaC says detailed advice on use and contraindications “will be available in the green book chikungunya chapter in the coming months.” Ask a travel clinic what the current position is when you book.

The mosquitoes that spread chikungunya bite in daylight, which catches out people who think of mosquitoes as a dusk problem. Repellent at breakfast and long sleeves at a lunchtime café matter as much as a net at night.

The wet season adds standing water, and standing water is breeding habitat. Our rainy-season guide covers what the wet months change in Bali, and the same bite-avoidance routine protects against dengue, Zika and chikungunya at once — three diseases, one habit.

Information on current outbreaks is published on NaTHNaC's outbreak surveillance pages. If one is reported where you live, that is the first group in its vaccine advice, and the point to talk to a clinic.

An infection caught after arrival is an acute illness and sits on the ordinary side of a health policy. The harder question is the long tail. If joint pain persists for months or years, read the policy's chronic conditions exclusion — chronic conditions are excluded unless the plan includes a Chronic Conditions benefit. That is a question to ask before buying, not after the pain has stayed.

The vaccine is usually your cost: on the plans we arrange, vaccinations are not covered on Major Medical or Standard, with US$250 at 25% co-insurance on Comprehensive and US$500 on Fully Comprehensive, limited to travel-requirement vaccinations.

On the public side, Indonesia's national scheme defines its participants as including foreigners who have worked in Indonesia for at least six months. A retiree or a remote worker paid from abroad is not the case that rule describes, and private cover is what serves those years. The cover we arrange is worldwide — the United States is the one exception — and pre-existing conditions are excluded.